Cargando…

Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Jeantin, Lina, Hesters, Adèle, Fournier, Dorine, Lebrun-Vignes, Bénédicte, Méneret, Aurélie, Papeix, Caroline, Touitou, Valérie, Maillart, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034694/ https://www.ncbi.nlm.nih.gov/pubmed/35460339 http://dx.doi.org/10.1007/s00415-022-11130-x

Ejemplares similares

Myélite, névrite optique et hypertension intracrânienne dans le cadre d’une maladie à anti-MOG après vaccination anti-COVID-19 : à propos d’un cas et revue de la littérature
por: Jeantin, Lina, et al.
Publicado: (2022)

COVID-19 vaccine post-marketing surveillance: Cardiovascular doctors have a role to play!
por: Fournier, Dorine, et al.
Publicado: (2021)

Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease
por: Shambrook, Pauline, et al.
Publicado: (2021)

COVID-19 infection in NMO/SD patients: a French survey
por: Zeidan, Sinéad, et al.
Publicado: (2020)

Atypical Presentation of Anti-MOG Ab Disease
por: Bhoi, Sanjeev K., et al.
Publicado: (2021)

Recurrent Idiopathic Neuroretinitis: Anti-MOG Positive?
por: Mizera, Thomas, et al.
Publicado: (2023)

Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center
por: Roux, Thomas, et al.
Publicado: (2017)

Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
por: Lana-Peixoto, Marco A., et al.
Publicado: (2019)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Anti-MOG encephalitis mimicking small vessel CNS vasculitis
por: Patterson, Kristina, et al.
Publicado: (2019)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
por: Fovet, Claire-Maëlle, et al.
Publicado: (2019)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis
por: Sterlin, Delphine, et al.
Publicado: (2021)

Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
por: Maillart, Elisabeth, et al.
Publicado: (2020)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Vaccination contre le SARS-CoV-2 avant l’introduction d’un traitement par anti-CD20 chez les patients atteints de sclérose en plaques : une protection durable ?
por: Jeantin, Lina, et al.
Publicado: (2023)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Reversible paraspinal muscle hyperintensity in anti-MOG antibody–associated transverse myelitis
por: Pandit, Lekha, et al.
Publicado: (2017)

Positive anti-MOG antibodies in a patient with Sjögren’s syndrome and transverse myelitis
por: Jobling, Kerry, et al.
Publicado: (2019)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
por: Berg, Carsten Tue, et al.
Publicado: (2017)

Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment
por: Takahashi, Keita, et al.
Publicado: (2021)

Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study
por: Papeix, Caroline, et al.
Publicado: (2015)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review
por: Nguyen, Lee S., et al.
Publicado: (2021)

Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
por: Louapre, C., et al.
Publicado: (2020)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
por: de Mol, CL, et al.
Publicado: (2019)

Transient Tunnel Vision as Initial Presentation of Anti-MOG Antibody Positive Optic Neuritis
por: Prabhakar, Appaswamy T., et al.
Publicado: (2021)

ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination
por: Mumoli, Laura, et al.
Publicado: (2021)

AZD-1222: Acute disseminated encephalomyelitis anti-MOG antibody‑positive: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_acvf6m6ff2065ss1sug2s9vkun